Top Markets
Coin of the day
IMBdx IMBdx

IMBdx

461030
Rankning i aktier #27729
IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for... IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for cancer detection and management. The company's core mission revolves around three key areas: facilitating the diagnosis and treatment strategies for advanced-stage cancers, enabling the early identification of cancer recurrence after surgical interventions, and providing solutions for the early diagnosis of cancer. Its notable product offerings include AlphaLiquid, CancerDetect, and CancerFind. The firm was established by Tae-Yu Kim, Sung-Tae Moon, and Doo-Hee Bang on July 5, 2018, and maintains its headquarters in Seoul, South Korea.
Aktiekurs
$2.17
Marknadsvärde
$31.07M
Förändring (1 dag)
1.62%
Förändring (1 år)
-61.54%
Land
KR
Handel IMBdx (461030)

Kategori

Historik för aktiesplit för IMBdx (461030)
Aktien IMBdx (symbol: 461030) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 20, 2026.
En 461030-aktie köpt före Aug 20, 2026 motsvarar nu 0 461030-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH